| Ticker Details |
|
Erasca, Inc.
|
| IPO Date: |
July 16, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$2.78B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.21 | 3.76%
|
| Avg Daily Range (30 D): |
$0.34 | 6.93%
|
| Avg Daily Range (90 D): |
$0.17 | 4.94%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.01M |
| Avg Daily Volume (30 D): |
5.39M |
| Avg Daily Volume (90 D): |
2.89M |
| Trade Size |
| Avg Trade Size (Sh.): |
143 |
| Avg Trade Size (Sh.) (30 D): |
180 |
| Avg Trade Size (Sh.) (90 D): |
175 |
| Institutional Trades |
| Total Institutional Trades: |
541 |
| Avg Institutional Trade: |
$1.84M |
| Avg Institutional Trade (30 D): |
$1.44M |
| Avg Institutional Trade (90 D): |
$1.29M |
| Avg Institutional Trade Volume: |
.4M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.58M |
| Avg Closing Trade (30 D): |
$1.93M |
| Avg Closing Trade (90 D): |
$1.58M |
| Avg Closing Volume: |
544.24K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.11
|
$-.12
|
$-.11
|
|
Diluted EPS
|
$-.11
|
$-.12
|
$-.11
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-30.61M
|
$-33.88M
|
$-30.97M
|
|
Operating Income / Loss
|
$-34.55M
|
$-38.13M
|
$-35.63M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$4.09M
|
$-4.34M
|
$2.74M
|
|
PE Ratio
|
|
|
|
|
|
|